We're trimming a rallying defensive stock and buying other on a muted earnings move
Jim Cramer's Charitable Trust is selling 50 shares of Cardinal Health (CAH) at $251 each, reducing its stake to 425 shares. It is buying 75 shares of Bank of New York (BNY) at $138, increasing its position to 675 shares. CAH is up 5% this week, while BNY reported better-than-expected earnings with $5.7B revenue and $2.37 EPS.
How this was made

The 30-second read
Why it matters
The piece provides no new corporate events beyond the earnings beat for BNY; its primary purpose is to signal the trust's trades.
Market read
A promotional trade recommendation with modest relevance; the only fresh data is BNY's earnings beat, which is already reflected in market pricing.
What to watch
Potential hidden upside in BNY if fee‑based revenue growth sustains beyond the quarter.
Background
The article is a trade alert from Jim Cramer's CNBC Investing Club, outlining a portfolio rebalancing ahead of a live monthly meeting.
Ticker impact
Cardinal Health is being trimmed after a rally above $250, with the trust selling 50 shares at $251.
potential short-term decline as the market prices the sell order
The trade is a deliberate profit‑taking move; no new corporate news is driving the price.
Bank of New York reported a better‑than‑expected quarter with $5.7 B revenue and $2.37 EPS, prompting the trust to buy 75 shares at $138.
short‑term support from the buy and earnings beat
Earnings beat is fresh information, but the article is a promotional trade note rather than a market‑moving event.
Market effects
The note reflects a broader rotation from AI‑heavy names to defensive healthcare and financials.
U.S. equity market, primarily large‑cap defensive sectors.
Limited to U.S. investors following the CNBC Investing Club.
Counterpoint
The sell of CAH may be premature if the distribution agreement with CVS continues to support the rally.
Key entities
- companyCardinal Health
Defensive health‑care distributor, subject of a sell trade.
- companyBank of New York
Financial services firm, subject of a buy trade after earnings beat.



